Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Promino Nutritional Sciences Inc C.MUSL

Alternate Symbol(s):  MUSLF

Promino Nutritional Sciences Inc., formerly Element Nutritional Sciences Inc., is a research-driven Canadian nutraceutical company. The Company is specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. The Company's lead product, Rejuvenate, is a formulation that is clinically proven to assist in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Rejuvenate helps boost energy and strengthen the metabolism and immune system. The Company also offers Promino, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury.


CSE:MUSL - Post by User

Post by waves1on Apr 04, 2022 4:23pm
78 Views
Post# 34574441

"$ELMT is poised to enter a hyper-growth stage"

"$ELMT is poised to enter a hyper-growth stage"
Great intro to Element Nutritional Sciences ($ELMT.c $EKNSF) from Benzinga 
https://www.youtube.com/watch?v=Iw4Qcv-4VwE&ab_channel=Benzinga
 
Benzinga notes that $ELMT is poised to enter a hyper-growth stage as large retailers have been stocking their products and they recently received the largest purchase order to date, indicating increasing retailer interest.
 
$ELMT's executive team has a proven track record of building products, growing sales, and exploding companies into high growth, plus, the founder has invested $3.2M and owns 20% of the shares himself. 
 
Backed by clinical studies, patents, and $20M in investments, $ELMT is looking like a solid science-based play, focused on preventing age-related muscle loss IMO. 
<< Previous
Bullboard Posts
Next >>